Fluoride Ion

Fluoride Ion

SCHEMBL915812

O=[Si]([O-])[O-].O=[Si]([O-])[O-].O=[Si]([O-])[O-].[Al+3].[Al+3].[F-].[F-].[F-].[K+].[K+].[Mg+2].[Mg+2].[OH-].[OH-].[OH-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Fluoride Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride Ion SCHEMBL665695 0.96
Fluoride Ion SCHEMBL914181 0.95
Potassium Ion SCHEMBL664230 0.95
Fluoride Ion SCHEMBL5552421 0.95
Potassium Ion SCHEMBL664053 0.91
Fluoride Ion SCHEMBL14875172 0.91
Fluoride Ion SCHEMBL664724 0.91
Fluoride Ion SCHEMBL665320 0.91
Potassium Ion SCHEMBL5443042 0.91
Potassium Ion SCHEMBL665404 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361430-A1 NON-SWELLING HOT MELT ADHESIVE AVERY DENNISON CORP (US) 2025-11-27 US disclosed
EP-3784746-B1 NON-SWELLING HOT MELT ADHESIVE AVERY DENNISON CORP (US) 2025-09-10 EP disclosed
US-12404433-B2 Non-swelling hot melt adhesive AVERY DENNISON CORPORATION (US) 2025-09-02 US disclosed
US-20250256971-A1 Compositions and Methods for the Capture of Carbon Dioxide and/or the Generation of Silica OHIO STATE INNOVATION FOUNDATION 2025-08-14 US disclosed
US-12168747-B2 Aerogel compositions for high temperature applications ASPEN AEROGELS, INC. (US) 2024-12-17 US disclosed
US-20240360363-A1 AEROGEL COMPOSITIONS FOR HIGH TEMPERATURE APPLICATIONS ASPEN AEROGELS, INC. 2024-10-31 US disclosed
US-11771716-B2 Nanoclays for the control of melanoma cell proliferation and cell viability KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2023-10-03 US disclosed
US-11634641-B2 Aerogel compositions for high temperature applications ASPEN AEROGELS, INC. (US) 2023-04-25 US disclosed
US-11549059-B2 Aerogel compositions with enhanced performance MIDCAP FUNDING IV TRUST 2023-01-10 US disclosed
WO-2022047029-A1 PROPPANT MATERIALS HEXION INC. (US) 2022-03-03 WO disclosed
WO-2007140293-A2 AEROGEL COMPOSITIONS WITH ENHANCED PERFORMANCE ASPEN AEROGELS, INC. (US) 2007-12-06 WO disclosed
US-20070272902-A1 AEROGEL COMPOSITIONS WITH ENHANCED PERFORMANCE ASPEN AEROGELS, INC. (US) 2007-11-29 US disclosed
EP-1791575-A2 ADHESIVE COMPOSITION Corium International Inc., (US) 2007-06-06 EP disclosed
US-7217853-B2 Composition for cushions, wound dressings and other skin-contacting products CORIUM INTERNATIONAL, INC. (US) 2007-05-15 US disclosed
US-20070051376-A1 Composition for cushions, wounds dressings and other skin-contacting products CORIUM INTERNATIONAL, INC. (US) 2007-03-08 US disclosed
US-20060034905-A1 Adhesive composition CORIUM PHARMA SOLUTIONS, INC. 2006-02-16 US disclosed
WO-2006017807-A2 ADHESIVE COMPOSITION CORIUM INTERNATIONAL, INC. (US) 2006-02-16 WO disclosed
WO-2006017546-A1 ANIONIC-CONTAING FEED SUPPLEMENTS HAVING A LOW PROTEIN BY-PASS VALUE NOVUS INTERNATIONAL, INC. (US) 2006-02-16 WO disclosed
US-20060029646-A1 Anionic-containing feed supplements having a low protein by-pass value NOVUS INTERNATIONAL, INC. 2006-02-09 US disclosed
US-20030225356-A1 Composition for cushions, wound dressings and other skin-contacting products COLUMBUS INVESTMENT HOLDINGS SA (CH) 2003-12-04 US disclosed